TBPN cover image

Chip Bottleneck vs. Energy Bottleneck, Amazon’s $200B Capex, Big Tech Earnings | Doug O'Laughlin, Max Levchin, TJ Parker, Arsalan Tavakoli

TBPN

00:00

TJ Parker on HIMSS, Compounding Risks, and FDA

TJ outlines compounding history, legal/regulatory risks, and why Wagovi pill claims lack supporting efficacy data.

Play episode from 02:25:31
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app